[go: up one dir, main page]

CH647236A5 - N-aryl-n'-(2-imidazolidinyliden)-harnstoffe sowie arzneimittel zur behandlung von hypertonie und intestinalen stoerungen. - Google Patents

N-aryl-n'-(2-imidazolidinyliden)-harnstoffe sowie arzneimittel zur behandlung von hypertonie und intestinalen stoerungen. Download PDF

Info

Publication number
CH647236A5
CH647236A5 CH11419/79A CH1141979A CH647236A5 CH 647236 A5 CH647236 A5 CH 647236A5 CH 11419/79 A CH11419/79 A CH 11419/79A CH 1141979 A CH1141979 A CH 1141979A CH 647236 A5 CH647236 A5 CH 647236A5
Authority
CH
Switzerland
Prior art keywords
urea
imidazolidinylidene
content
treatment
medicament according
Prior art date
Application number
CH11419/79A
Other languages
German (de)
English (en)
Inventor
Chris Royce Rasmussen
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/972,580 external-priority patent/US4239768A/en
Priority claimed from US05/972,579 external-priority patent/US4229462A/en
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of CH647236A5 publication Critical patent/CH647236A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/38—Isothioureas containing any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CH11419/79A 1978-12-22 1979-12-21 N-aryl-n'-(2-imidazolidinyliden)-harnstoffe sowie arzneimittel zur behandlung von hypertonie und intestinalen stoerungen. CH647236A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/972,580 US4239768A (en) 1978-12-22 1978-12-22 Method for relieving irritable bowel syndrome symptoms
US05/972,579 US4229462A (en) 1978-12-22 1978-12-22 Method for controlling hypertension and compositions

Publications (1)

Publication Number Publication Date
CH647236A5 true CH647236A5 (de) 1985-01-15

Family

ID=27130555

Family Applications (1)

Application Number Title Priority Date Filing Date
CH11419/79A CH647236A5 (de) 1978-12-22 1979-12-21 N-aryl-n'-(2-imidazolidinyliden)-harnstoffe sowie arzneimittel zur behandlung von hypertonie und intestinalen stoerungen.

Country Status (23)

Country Link
AT (1) AT373878B (hu)
AU (2) AU532332B2 (hu)
CA (1) CA1127651A (hu)
CH (1) CH647236A5 (hu)
DE (1) DE2951213A1 (hu)
DK (1) DK548179A (hu)
ES (1) ES487159A0 (hu)
FI (1) FI66354C (hu)
FR (2) FR2444462B1 (hu)
GB (2) GB2040681B (hu)
GR (1) GR68018B (hu)
HU (1) HU183013B (hu)
IL (1) IL59019A (hu)
IT (1) IT1126839B (hu)
NL (1) NL7909265A (hu)
NO (1) NO794249L (hu)
NZ (1) NZ192453A (hu)
PH (1) PH16571A (hu)
PT (1) PT70624A (hu)
SE (1) SE7910612L (hu)
SU (1) SU971098A3 (hu)
YU (1) YU314979A (hu)
ZW (1) ZW25379A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US11516649B2 (en) * 2018-10-29 2022-11-29 Apple Inc. Mechanism to activate and manage a standalone device for cellular service

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1296962A (fr) * 1960-08-05 1962-06-22 Geigy Ag J R Nouveaux composés 2-imino-1.3-di-aza et leur préparation
NL267923A (hu) * 1960-08-05

Also Published As

Publication number Publication date
ES8101558A1 (es) 1980-12-16
ATA808979A (de) 1983-07-15
AU1640083A (en) 1983-11-17
NL7909265A (nl) 1980-06-24
FR2444462B1 (fr) 1986-08-29
GB2113204B (en) 1984-02-01
GB2040681A (en) 1980-09-03
DK548179A (da) 1980-06-23
GB2113204A (en) 1983-08-03
SE7910612L (sv) 1980-06-23
FI66354C (fi) 1984-10-10
HU183013B (en) 1984-04-28
PT70624A (en) 1980-01-01
FR2445321B1 (hu) 1983-08-26
AT373878B (de) 1984-02-27
YU314979A (en) 1983-02-28
PH16571A (en) 1983-11-18
FI66354B (fi) 1984-06-29
NO794249L (no) 1980-06-24
IT1126839B (it) 1986-05-21
AU566013B2 (en) 1987-10-08
IL59019A (en) 1984-05-31
GR68018B (hu) 1981-10-27
CA1127651A (en) 1982-07-13
IL59019A0 (en) 1980-03-31
SU971098A3 (ru) 1982-10-30
NZ192453A (en) 1982-09-07
FR2445321A1 (hu) 1980-07-25
GB2040681B (en) 1983-04-13
AU532332B2 (en) 1983-09-29
FR2444462A1 (fr) 1980-07-18
ES487159A0 (es) 1980-12-16
IT7951164A0 (it) 1979-12-21
AU5378079A (en) 1980-06-26
ZW25379A1 (en) 1981-07-22
DE2951213A1 (de) 1980-07-10
FI794036A (fi) 1980-06-23

Similar Documents

Publication Publication Date Title
DE2557438C2 (hu)
DD216929A5 (de) Verfahren zur herstellung von thiazolidinderivaten
EP0350448A1 (de) Biarylverbindungen
EP0062199B1 (de) N-(4-Aminobenzoyl)-N'-benzylbispidin, seine Herstellung und dieses enthaltende Arzneimittel
DD224033A5 (de) Verfahren zur herstellung substituierter 1,2,4-triazine und deren salze
CH661508A5 (de) 1,5-benzothiazepine mit cardiovascularer wirksamkeit, verfahren zu ihrer herstellung und pharmazeutische praeparate, welche diese verbindungen enthalten.
EP0104423B1 (de) 2-Nitro-1,1-ethendiamine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2847792C2 (hu)
DE1470088A1 (de) Verfahren zur Herstellung von in 6-Stellung substituierten 3-Aminopyrazinoylguanidinen
DE3940021C2 (de) Adenosin-Derivate, deren Herstellung und Verwendung
DE3035688C2 (hu)
DE2804518C2 (de) 5-[3,6-Dihydro-1(2H)-Pyridyl]-2 oxo-2H-[1,2,4]-oxadiazolo-[2,3-a]-pyrimidin-7-carbamate
CH647236A5 (de) N-aryl-n'-(2-imidazolidinyliden)-harnstoffe sowie arzneimittel zur behandlung von hypertonie und intestinalen stoerungen.
DE3618724A1 (de) N-(3-(nitro)-chinol-4-yl)-carboxamidinamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2518032A1 (de) 2-aminoimidazole, verfahren zu deren herstellung und dieselben enthaltendes mittel
DE3152942T1 (de) Heterocyclisch substituierte amidinoharnstoffe und ihre therapeutische anwendung
DE2939914A1 (de) N-(1-methyl-2-pyrrolidinylmethyl)-2,3- dimethoxy-5-methylsulfamoylbenzamid, verfahren zu seiner herstellung und seine therapeutische verwendung
DE3107599C2 (de) N-Cyan-N'-methyl-N"-{2-[(5-methylthio-imidazol-4-yl)-methylthio]-äthyl}-guanidin, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
DE3233380A1 (de) Substituierte pyridyl-cyanoguanidinverbindungen
CH579565A5 (en) Imidazolin-2-ylamino-2,1,3-benzothiadiazoles prodn. - by cyclising corresp. beta aminoethyl (thio) ureas, active against muscle tremors and rigor
DE2628642C2 (de) In 2-Stellung substituierte 1,3-Diaza-fünfringkohlenstoffverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE2233114A1 (de) Verfahren zur herstellung von isothiazolyl-verbindungen
EP0004904B1 (de) 2-Amino-3a,4,5,6-tetrahydro-perimidin-Derivate, diese enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AT390790B (de) Verfahren zur herstellung des neuen 3-amino-4-(2-((2-guanidinothiazol-4-yl)methylth o)-ethylamino)-1,2,5-thiadiazols
EP0492257A1 (de) Thiadiazinonderivate

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased